On May 29, 2019 Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company focused on the development and commercialization of therapeutics for patients with kidney disease, reported that John P. Butler, President and Chief Executive Officer of Akebia, will participate in the following investor conferences (Press release, Akebia, MAY 29, 2019, View Source [SID1234536654]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The Jefferies 2019 Healthcare Conference on Tuesday, June 4th at 3:00 p.m. Eastern Time at the Grand Hyatt New York.
The Raymond James Life Sciences and MedTech Conference on Wednesday, June 19th at 10:55 a.m. Eastern Time at the Lotte New York Palace.
A live webcast of the presentations will be available on the company’s website at www.akebia.com. A replay of the webcast will be available on Akebia’s website following the conference.